Armata Pharmaceuticals (ARMP) Capital Expenditures (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.15% |
| Dec 31, 2025 | -78.51% |
| Sep 30, 2025 | 62.42% |
| Jun 30, 2025 | 50.51% |
| Mar 31, 2025 | 228.57% |
| Dec 31, 2024 | -122.65% |
| Sep 30, 2024 | -75.11% |
| Jun 30, 2024 | 446.40% |
| Mar 31, 2024 | -89.58% |
| Dec 31, 2023 | -31.66% |
| Sep 30, 2023 | 1,481.98% |
| Jun 30, 2023 | -88.96% |
| Mar 31, 2023 | 541.76% |
| Dec 31, 2022 | -135.16% |
| Sep 30, 2022 | 13.91% |
| Jun 30, 2022 | 381.36% |
| Mar 31, 2022 | 3.51% |
| Dec 31, 2021 | -60.82% |
| Sep 30, 2021 | 196.94% |
| Jun 30, 2021 | -34.23% |
| Mar 31, 2021 | -18.58% |
| Dec 31, 2020 | 351.85% |
| Sep 30, 2020 | -70.33% |
| Jun 30, 2020 | 162.50% |
| Mar 31, 2020 | 395.24% |
| Dec 31, 2019 | 132.31% |
| Sep 30, 2019 | -151.59% |
| Jun 30, 2019 | -11.27% |
| Mar 31, 2019 | -63.68% |
| Dec 31, 2018 | 152.26% |
| Dec 31, 2017 | -45.45% |
| Sep 30, 2017 | 1,550.00% |
| Jun 30, 2017 | -60.00% |
| Mar 31, 2017 | -61.54% |
| Dec 31, 2016 | -55.17% |
| Sep 30, 2016 | -76.80% |
| Jun 30, 2016 | 11.61% |